126 related articles for article (PubMed ID: 30350751)
21. Incidence and survival of head and neck cancer in the Faroe Islands.
Olsen SH; Friborg J; Ellefsen B; Jakobsen KK; Aanæs K
Int J Circumpolar Health; 2021 Dec; 80(1):1894697. PubMed ID: 33719929
[No Abstract] [Full Text] [Related]
22. Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer.
Tham T; Olson C; Wotman M; Teegala S; Khaymovich J; Coury J; Costantino P
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2869-2878. PubMed ID: 30251123
[TBL] [Abstract][Full Text] [Related]
23. Impact of Type 2 Diabetes Mellitus on Survival in Head and Neck Squamous Cell Carcinoma.
Foreman A; Lee DJ; McMullen C; de Almeida J; Muhanna N; Gama RR; Giuliani M; Liu G; Bratman SV; Huang SH; O'Sullivan B; Song Y; Xu W; Goldstein DP
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):657-663. PubMed ID: 28849730
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
[TBL] [Abstract][Full Text] [Related]
25. A Pilot Study on Factors Associated with Presentation Delay in Patients Affected with Head and Neck Cancers.
Baishya N; Das AK; Krishnatreya M; Das A; Das K; Kataki AC; Nandy P
Asian Pac J Cancer Prev; 2015; 16(11):4715-8. PubMed ID: 26107229
[TBL] [Abstract][Full Text] [Related]
26. Epidemiological Trends of Head and Neck Cancer: A Population-Based Study.
Guo K; Xiao W; Chen X; Zhao Z; Lin Y; Chen G
Biomed Res Int; 2021; 2021():1738932. PubMed ID: 34337000
[TBL] [Abstract][Full Text] [Related]
27. Investigating Patient and Physician Delays in the Diagnosis of Head and Neck Cancers: a Canadian Perspective.
Lee JJ; Dhepnorrarat C; Nyhof-Young J; Witterick I
J Cancer Educ; 2016 Mar; 31(1):8-14. PubMed ID: 25566764
[TBL] [Abstract][Full Text] [Related]
28. Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer.
Chen MC; Huang WC; Chan CH; Chen PT; Lee KD
Oral Oncol; 2010 Apr; 46(4):249-54. PubMed ID: 20138797
[TBL] [Abstract][Full Text] [Related]
29. Socioeconomic status, human papillomavirus, and overall survival in head and neck squamous cell carcinomas in Toronto, Canada.
Chu KP; Habbous S; Kuang Q; Boyd K; Mirshams M; Liu FF; Espin-Garcia O; Xu W; Goldstein D; Waldron J; O'Sullivan B; Huang SH; Liu G
Cancer Epidemiol; 2016 Feb; 40():102-12. PubMed ID: 26706365
[TBL] [Abstract][Full Text] [Related]
30. Pediatric head and neck squamous cell carcinoma: Patient demographics, treatment trends and outcomes.
Modh A; Gayar OH; Elshaikh MA; Paulino AC; Siddiqui F
Int J Pediatr Otorhinolaryngol; 2018 Mar; 106():21-25. PubMed ID: 29447885
[TBL] [Abstract][Full Text] [Related]
31. Homicide in Greenland 1985-2010.
Christensen MR; Thomsen AH; Høyer CB; Gregersen M; Banner J
Forensic Sci Med Pathol; 2016 Mar; 12(1):40-9. PubMed ID: 26603045
[TBL] [Abstract][Full Text] [Related]
32. Forty years of monitoring head and neck cancer in Norway--no good news.
Mork J
Anticancer Res; 1998; 18(5B):3705-8. PubMed ID: 9854481
[TBL] [Abstract][Full Text] [Related]
33. Tumor Necrosis Factor Inhibition and Head and Neck Cancer Recurrence and Death in Rheumatoid Arthritis.
Phillips C; Zeringue AL; McDonald JR; Eisen SA; Ranganathan P
PLoS One; 2015; 10(11):e0143286. PubMed ID: 26599370
[TBL] [Abstract][Full Text] [Related]
34. Second course of radiation for new primary head-and-neck cancer: population-based study of survival.
Milano MT; Zhang H
Am J Clin Oncol; 2011 Aug; 34(4):367-71. PubMed ID: 20859195
[TBL] [Abstract][Full Text] [Related]
35. Desmoplastic Melanoma of the Head and Neck: Incidence and Survival, 1992-2013.
Khan F; Strohl A; Allen PD; Doerr TD
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):648-656. PubMed ID: 28828926
[TBL] [Abstract][Full Text] [Related]
36. A population-based comparison of European and North American sinonasal cancer survival.
Unsal AA; Kılıç S; Dubal PM; Baredes S; Eloy JA;
Auris Nasus Larynx; 2018 Aug; 45(4):815-824. PubMed ID: 29056464
[TBL] [Abstract][Full Text] [Related]
37. Pattern of head and neck cancer in Yemen.
Abdul-Hamid G; Saeed NM; Al-Kahiry W; Shukry S
Gulf J Oncolog; 2010 Jan; (7):21-4. PubMed ID: 20164005
[TBL] [Abstract][Full Text] [Related]
38. Incidence of pancreatic cancer in Greenland 2000-2010.
Kirkegaard J
Int J Circumpolar Health; 2012 May; 71():18368. PubMed ID: 22663941
[TBL] [Abstract][Full Text] [Related]
39. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
Chau NG; Hurwitz S; Mitchell CM; Aserlind A; Grunfeld N; Kaplan L; Hsi P; Bauer DE; Lathan CS; Rodriguez-Galindo C; Tishler RB; Haddad RI; Sallan SE; Bradner JE; French CA
Cancer; 2016 Dec; 122(23):3632-3640. PubMed ID: 27509377
[TBL] [Abstract][Full Text] [Related]
40. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
